Nautilus Biotechnology Inc (NAUT)
2.69
+0.02
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Price to Book Value: 1.351 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.351 |
| May 02, 2024 | 1.341 |
| May 01, 2024 | 1.396 |
| April 30, 2024 | 1.275 |
| April 29, 2024 | 1.290 |
| April 26, 2024 | 1.250 |
| April 25, 2024 | 1.185 |
| April 24, 2024 | 1.205 |
| April 23, 2024 | 1.250 |
| April 22, 2024 | 1.215 |
| April 19, 2024 | 1.235 |
| April 18, 2024 | 1.175 |
| April 17, 2024 | 1.220 |
| April 16, 2024 | 1.265 |
| April 15, 2024 | 1.235 |
| April 12, 2024 | 1.240 |
| April 11, 2024 | 1.320 |
| April 10, 2024 | 1.285 |
| April 09, 2024 | 1.320 |
| April 08, 2024 | 1.356 |
| April 05, 2024 | 1.341 |
| April 04, 2024 | 1.326 |
| April 03, 2024 | 1.391 |
| April 02, 2024 | 1.361 |
| April 01, 2024 | 1.506 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.386 |
| March 27, 2024 | 1.306 |
| March 26, 2024 | 1.230 |
| March 25, 2024 | 1.249 |
| March 22, 2024 | 1.249 |
| March 21, 2024 | 1.301 |
| March 20, 2024 | 1.287 |
| March 19, 2024 | 1.226 |
| March 18, 2024 | 1.235 |
| March 15, 2024 | 1.207 |
| March 14, 2024 | 1.179 |
| March 13, 2024 | 1.245 |
| March 12, 2024 | 1.198 |
| March 11, 2024 | 1.136 |
| March 08, 2024 | 1.405 |
| March 07, 2024 | 1.386 |
| March 06, 2024 | 1.264 |
| March 05, 2024 | 1.230 |
| March 04, 2024 | 1.268 |
| March 01, 2024 | 1.282 |
| February 29, 2024 | 1.268 |
| February 28, 2024 | 1.32 |
| February 27, 2024 | 1.386 |
| February 26, 2024 | 1.282 |
| February 23, 2024 | 1.325 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5942
Minimum
Dec 16 2022
3.213
Maximum
Jun 30 2021
1.344
Average
1.313
Median
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 19.18 |
| Geron Corp | 6.759 |
| TG Therapeutics Inc | 1.641 |
| Editas Medicine Inc | 1.329 |
| G1 Therapeutics Inc | 6.623 |
Price to Book Value Related Metrics
| Price | 2.69 |
| Earnings Yield | -20.45% |
| Market Cap | 336.96M |